# EDGAR Filing Document

**Accession Number:** 0001865782
**File Stem:** 0000908834-25-000196
**Filing Date:** 2025-6
**Character Count:** 7371
**Document Hash:** 03be35589539e791f800f1ff022ca4f7
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000908834-25-000196.hdr.sgml**: 20250613

**ACCESSION NUMBER**: 0000908834-25-000196

**CONFORMED SUBMISSION TYPE**: 4

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20250612

**FILED AS OF DATE**: 20250613

**DATE AS OF CHANGE**: 20250613

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** ROUSSEAU JON B
- **CENTRAL INDEX KEY:** 0001579775

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-41938
- **FILM NUMBER:** 251046377

**MAIL ADDRESS:**
- **STREET 1:** 805 N. WHITTINGTON PARKWAY
- **CITY:** LOUISVILLE
- **STATE:** KY
- **ZIP:** 40222
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** BrightSpring Health Services, Inc.
- **CENTRAL INDEX KEY:** 0001865782
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-HOME HEALTH CARE SERVICES [8082]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 822956404
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 805 N. WHITTINGTON PARKWAY
- **CITY:** LOUISVILLE
- **STATE:** KY
- **ZIP:** 40222
- **BUSINESS PHONE:** 502-394-2100

**MAIL ADDRESS:**
- **STREET 1:** 805 N. WHITTINGTON PARKWAY
- **CITY:** LOUISVILLE
- **STATE:** KY
- **ZIP:** 40222

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 4

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[ ] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>ROUSSEAU JON B<br><sub>(Last) (First) (Middle)</sub><br>C/O BRIGHTSPRING HEALTH SERVICES, INC.<br>805 N. WHITTINGTON PARKWAY<br><sub>(Street)</sub><br>LOUISVILLE, KY 40222<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2025-06-12 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[X] Director [ ] 10% Owner<br>[X] Officer (give title below) [ ] Other (specify below)<br>_See Remarks_ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>BrightSpring Health Services, Inc. [ BTSG ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| Common Stock | 2025-06-12 |  | M |  | 531840 | A | $6.37 | 1715973<sup>(2)</sup> | D |  |
| Common Stock | 2025-06-12 |  | S<sup>(1)</sup> |  | 531840 | D | 21.75<sup>(1)</sup> | 1184133<sup>(2)</sup> | D |  |
| Common Stock |  |  |  |  |  |  |  | 369763 | I | By Rousseau Family Trust<sup>(4)</sup> |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| Stock Options (Right to Buy) | $6.37 | 2025-06-12 |  | M |  |  | 531840 | <sup>(3)</sup> | 2029-10-16 | Common Stock | 531840 | $0 | 795241 | D |  |
| Stock Options (Right to Buy) | $6.37 |  |  |  |  |  |  | <sup>(3)</sup> | 2029-10-16 | Common Stock | 534676 |  | 534676 | I | By The Margaret Rousseau Children Trust<sup>(4)</sup> |
| Stock Options (Right to Buy) | $6.37 |  |  |  |  |  |  | <sup>(3)</sup> | 2029-10-16 | Common Stock | 377602 |  | 377602 | I | By Rousseau Family Trust<sup>(4)</sup> |

---

### Footnotes:

(1) These shares of the Issuer's common stock were sold by the Reporting Person pursuant to a registered public offering that closed on June 12, 2025, at a price of $21.75, before deducting underwriting discounts and commissions.

(2) Includes 564,599 shares of the Issuer's common stock underlying restricted stock units ("RSUs") which will vest in seven equal quarterly installments commencing on July 25, 2025 and 316,639 shares of the Issuer's common stock underlying RSUs which vest in eleven equal quarterly installments commencing on July 25, 2025. Each RSU represents a contingent right to receive one share of common stock upon settlement.

(3) These options are fully vested.

(4) The Reporting Person states that this filing shall not be an admission that the Reporting Person is the beneficial owner of any of the securities reported herein as indirectly owned, and the Reporting Person disclaims beneficial ownership of such securities except to the extent of the Reporting Person's pecuniary interest therein.

**Remarks:**
Title: Chairman, President and Chief Executive Officer

**Signature:** /s/ Jennifer Phipps, as Attorney-in-Fact  
**Date:** 2025-06-13

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**